Synthesis and antitumor activities of novel rhein α-aminophosphonates conjugates

Bioorg Med Chem Lett. 2014 Jan 15;24(2):501-7. doi: 10.1016/j.bmcl.2013.12.030. Epub 2013 Dec 16.

Abstract

Several rhein α-aminophosphonates conjugates (5a-5q) were synthesized and evaluated for in vitro cytotoxicity against HepG-2, CNE, Spca-2, Hela and Hct-116 cell lines. Some compounds showed relatively high cytotoxicity. Especially, compound 5i exhibited the strongest cytotoxicity against Hct-116 cells (IC50 was 5.32 μM). All the synthesized compounds exhibited low cytotoxicity against HUVEC cells. The mechanism of compound 5i was preliminarily investigated by Hoechst 33258 staining, JC-1 mitochondrial membrane potential staining and flow cytometry, which indicated that the compound 5i induced apoptosis in Hct-116 cancer cells. Cell cycle analysis showed that these compound 5i mainly arrested Hct-116 cells in G1 stage. The effects of 5i on the activation of caspases expression indicated that 5i might induce apoptosis via the membrane death receptor pathways. In addition, the binding properties of a model analog 5i to DNA were investigated by methods (UV-vis, fluorescence, CD spectroscopy and FRET-melting) in compare with that of rhein. Results indicated that 5i showed moderate ability to interact ct-DNA.

Keywords: Apoptosis; Cytotoxicity; DNA binding; Rhein; Synthesis; α-Aminophosphonates.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anthraquinones / chemical synthesis*
  • Anthraquinones / pharmacology
  • Antineoplastic Agents / chemical synthesis*
  • Antineoplastic Agents / pharmacology
  • Cell Cycle Checkpoints / drug effects
  • Cell Cycle Checkpoints / physiology
  • HCT116 Cells
  • HeLa Cells
  • Hep G2 Cells
  • Humans
  • Organophosphonates / chemical synthesis*
  • Organophosphonates / pharmacology

Substances

  • Anthraquinones
  • Antineoplastic Agents
  • Organophosphonates
  • rhein